Aspen Aerogels (NYSE:ASPN) Downgraded to "Sell" Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Aspen Aerogels to “Sell” from “Hold,” while analysts remain divided: four rate the stock Buy, one Hold and two Sell. The consensus rating is “Hold,” with an average price target of $5.94.
• Aspen Aerogels reported a quarterly loss of $0.22 per share, slightly better than estimates, and revenue of $49.85 million versus expectations of $42.42 million. However, the company continues to post negative profitability metrics and expects full-year EPS of approximately -$0.69.
• The stock opened at $5.85, with a market capitalization of about $486 million and a 52-week range of $2.30 to $9.35. Institutional investors and hedge funds own approximately 97.64% of the shares.

Aspen Aerogels (NYSE:ASPN - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Saturday.

Other equities research analysts also recently issued research reports about the stock. Barclays upped their target price on shares of Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research note on Tuesday. B. Riley Financial reissued a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a report on Wednesday, June 24th. Finally, Roth Capital restated a "buy" rating and issued a $7.75 price objective on shares of Aspen Aerogels in a research report on Friday, August 7th. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $5.94.

Aspen Aerogels Price Performance

Aspen Aerogels stock opened at $5.85 on Friday. The firm has a market capitalization of $485.82 million, a P/E ratio of -3.83 and a beta of 2.99. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.35. The business has a 50-day moving average of $5.51 and a 200-day moving average of $4.51. The company has a current ratio of 2.52, a quick ratio of 2.54 and a debt-to-equity ratio of 0.36.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. The company had revenue of $49.85 million during the quarter, compared to analysts' expectations of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. On average, equities analysts anticipate that Aspen Aerogels will post -0.69 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors and hedge funds have recently modified their holdings of the business. Rice Hall James & Associates LLC lifted its stake in Aspen Aerogels by 9.2% in the first quarter. Rice Hall James & Associates LLC now owns 1,552,628 shares of the construction company's stock valued at $5,310,000 after buying an additional 131,023 shares in the last quarter. Needham Investment Management LLC increased its position in shares of Aspen Aerogels by 26.5% during the fourth quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company's stock worth $12,315,000 after acquiring an additional 912,000 shares in the last quarter. Lazard Asset Management LLC bought a new stake in shares of Aspen Aerogels during the first quarter worth $485,000. First Eagle Investment Management LLC raised its holdings in shares of Aspen Aerogels by 20.3% during the fourth quarter. First Eagle Investment Management LLC now owns 622,487 shares of the construction company's stock worth $1,762,000 after acquiring an additional 105,164 shares during the period. Finally, Pallas Capital Advisors LLC acquired a new stake in shares of Aspen Aerogels during the second quarter worth $69,000. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source